Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.
Fiche publication
Date publication
mars 2015
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry
Tous les auteurs :
Levy A, Azria D, Pignon JP, Delarochefordiere A, Martel-Lafay I, Rio E, Malka D, Conroy T, Miglianico L, Becouarn Y, Malekzadeh K, Leclercq J, Juzyna B, Ezra P, Lemanski C, Deutsch E
Lien Pubmed
Mots clés
Antibodies, Monoclonal, Humanized, therapeutic use, Anus Neoplasms, radiotherapy, Cetuximab, Chemoradiotherapy, Clinical Trials, Phase II as Topic, Humans
Référence
Radiother Oncol. 2015 Mar;114(3):415-6